Zilia is a medical device company that prevents, diagnose, and treats various ocular, neurological, and systemic conditions.
Zilia's investors include Creative Destruction Lab, Anges Quebec, Investissement Quebec, Campus des Technologies de la Santé/CTS Healthcare, CQIB.
Zilia is headquartered in Quebec, Canada.
Zilia is a medical device company that prevents, diagnose, and treats various ocular, neurological, and systemic conditions.
Zilia is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zilia — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/zilia. Accessed November 4, 2026.
VCBacked. (2025). Zilia — Funding & Investors. Retrieved November 4, 2026, from https://www.vcbacked.co/company/zilia
{{cite web |title=Zilia — Funding & Investors |url=https://www.vcbacked.co/company/zilia |website=VCBacked |access-date=November 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Zilia? Request a listing update